Lorastad (loratadine)

Quick links

Choose a section

Quick links to important sections

Advertisements

Lorastad (loratadine)

Advertisements
Advertisements

Overview of Lorastad (loratadine)

Property Description
Active ingredient Loratadine
Form Tablet (oral), Capsule, Syrup/Solution (oral)
Pharmacological class Second-Generation Antihistamine
Common use Symptomatic relief of allergies
Origin Synthetic, Piperidine derivative

What is Loratadine and How is it Classified?

Loratadine is the single active pharmaceutical ingredient (API) within the medicine Lorastad, belonging to the second-generation antihistamine class. The drug is a synthetic tricyclic compound and a piperidine derivative, specifically developed for anti-allergic action. This classification confirms that the medicine primarily targets peripheral histamine receptors, leading to its effective use in relieving allergy symptoms.

This classification is crucial because the compound’s structure results in minimal penetration of the blood-brain barrier. This mechanism is associated with its non-sedating profile, a characteristic that differentiates it from older antihistamines. Loratadine is clinically recognized for its reliable efficacy in treating typical seasonal allergic rhinitis.


The Physical Composition and General Purpose of Lorastad

Loratadine is prepared for oral administration and is supplied in several distinct dosage forms, including the standard tablet, chewable tablets, and an oral syrup or solution. The primary general purpose of this medicine is to provide long-acting, 24-hour anti-allergic relief from a single daily intake, which is a key differentiating feature for adherence and continuous symptom control.

Its high-level composition relies solely on Loratadine as the active component, combined with necessary excipients—such as lactose and starch in solid forms—which ensure the stable, controlled release of the medicine. The consistent efficacy and duration of action make it a widely utilized agent for the once-daily management of symptoms.


Loratadine versus Desloratadine: Understanding the Difference

While Loratadine is the administered parent compound, its therapeutic effect is substantially maintained by its active metabolite, desloratadine. This metabolite is formed rapidly in the body following oral intake and is known to be highly potent. This metabolic conversion is essential for the drug's extended duration of action, providing continuous peripheral H1-receptor antagonistic activity through both the parent compound and its long-lived derivative.

Regulatory References

  1. Loratadine - StatPearls
  2. DailyMed: Desloratadine
Advertisements

What side effects are possible with Lorastad (loratadine)?

Possible Side Effects and Safety Information

The safety profile for loratadine is categorized based on adverse reactions officially documented in government regulatory sources, classified by frequency and affected body systems.

Frequency-Classified Adverse Reactions

The assignment of frequency follows regulatory standards (e.g., Common: ge 1/100 to < 1/10).

Classification Examples of Documented Adverse Reactions
Common Headache, somnolence (drowsiness), fatigue (more commonly reported in adults and adolescents)
Uncommon Insomnia, increased appetite (as per some regulatory lists)
Very Rare Dizziness, tachycardia, palpitations, nausea, abnormal hepatic function, rash, alopecia, anaphylaxis, seizures

System-Organ-Class and Serious Reactions

Adverse reactions are formally grouped into affected body systems. These include Nervous System Disorders (e.g., somnolence, headache), Gastrointestinal Disorders (e.g., dry mouth, nausea), and, rarely, Cardiac Disorders (e.g., tachycardia, palpitation).

Serious Adverse Reactions officially documented, typically occurring very rarely, include severe hypersensitivity reactions such as anaphylaxis and angioedema, as well as seizures and complications related to abnormal hepatic function.


Population-Specific Safety Considerations

Specific safety statements are noted for certain patient groups. Caution is documented for patients with severe hepatic impairment due to reduced drug clearance, and some regulatory documents recommend considering a lower initial dose in this population. Increased drug concentrations may also occur in patients with chronic renal impairment.

Safety-Related Limitations

Loratadine is contraindicated in individuals with known hypersensitivity to the active substance or any of its ingredients. Official labeling also includes a high-level safety note regarding the potential for increased drug levels when loratadine is administered alongside substances that inhibit Cytochrome P450 enzymes (CYP3A4 or CYP2D6).

Advertisements

Overdose and Emergency Response

The regulatory documents for loratadine specify that immediate medical attention must be sought if an overdose is suspected. This involves the mandated action to contact a Poison Control Center right away or the nearest casualty department.

The official regulatory profile confirms that overdosage with loratadine increases the occurrence of anticholinergic symptoms. The specific clinical manifestations reported with overdose include somnolence (drowsiness), tachycardia (fast heart rate), and headache.

In the event of overdosage, general symptomatic and supportive measures are to be instituted and maintained for as long as necessary. Procedural management may involve the administration of activated charcoal as a slurry with water, and gastric lavage may be considered by medical professionals. It is officially noted that loratadine is not removed by haemodialysis.

After emergency treatment, medical monitoring of the patient must be continued to ensure stability. Furthermore, regulatory documents advise that patients with severe liver impairment may have reduced drug clearance, which increases their susceptibility to overdose effects. These officially documented facts define the required emergency medical response and necessary patient observation following excessive ingestion.

Advertisements

Therapeutic Uses of Lorastad (loratadine)

Lorastad (loratadine): Main Uses and Benefits

Lorastad (loratadine) is utilized to address symptoms related to allergic conditions. Its primary function is to contribute to the relief of discomfort caused by both seasonal allergic rhinitis (commonly known as hay fever) and perennial allergic rhinitis (symptoms occurring year-round).

Key symptoms that the medication may assist in managing include:

  • Runny nose
  • Sneezing
  • Itching of the nose or throat
  • Itchy, watery eyes

Additionally, loratadine is indicated for the temporary amelioration of symptoms associated with chronic idiopathic urticaria (chronic hives of unknown cause). This includes calming the skin itching and reducing the number and size of hives (wheals) that manifest on the skin.

The medication serves to mitigate the body's reaction to allergens, helping to support patient comfort during allergic episodes.


Quick Facts

  • Treats symptoms of seasonal and perennial allergic rhinitis (hay fever and year-round allergies).
  • Addresses discomfort from runny nose, sneezing, and itching (of the eyes, nose, or throat).
  • Provides relief from symptoms of chronic idiopathic urticaria (hives and associated itching).

Regulatory References

  1. NIH MedlinePlus guidance on Loratadine
Advertisements

Eligibility and Restrictions for Use

Lorastad (loratadine) eligibility is determined by specific regulatory criteria relating to age, underlying health conditions, and physiological state.

Contraindications and Prohibitions

The medicine is contraindicated and must not be used by individuals with a known hypersensitivity to loratadine, its active metabolite (desloratadine), or any excipients in the formulation. Patients with rare hereditary disorders, such as galactose intolerance or total lactase deficiency, are also precluded from using certain tablet forms due to excipient content.

Age and Physiological Restrictions

Use is not established for children under two years of age. While loratadine is generally approved for patients aged two years and older, regulatory guidance advises against self-medication for children aged two to five years. The medicine is also not recommended for use during pregnancy or breastfeeding due to precautionary measures.

Conditional Use

Special restrictions apply to patients with compromised organ function. Those with severe hepatic impairment (severe liver disease) or severe renal impairment must use loratadine with caution, as a dose adjustment is officially recommended.

Advertisements

What should I know about interactions with other medicines?

Loratadine is metabolized in the liver primarily by the cytochrome P450 enzymes CYP3A4 and, to a lesser extent, CYP2D6. Concomitant use with other medications that inhibit these enzymes can lead to elevated levels of loratadine in the bloodstream.

Documented Pharmacokinetic Interactions

Specific medicines that have been shown to increase loratadine plasma concentrations by inhibiting its metabolism include the antifungal ketoconazole, the antibiotic erythromycin, and the anti-ulcer medication cimetidine. In controlled clinical trials, the resultant increases in drug concentrations from these interactions were generally not associated with clinically significant changes, including in the electrocardiogram (ECG) assessments.

However, due to the potential for increased systemic exposure, caution is advised when loratadine is used concurrently with any potent inhibitor of CYP3A4 or CYP2D6. Patients with severe liver impairment should also use loratadine cautiously, as reduced drug clearance may lead to higher concentrations.

Interaction Type Examples of Interacting Products
Inhibitors of Metabolism (CYP450) Ketoconazole, Erythromycin, Cimetidine, Mavorixafor

Interaction-Related Procedural Constraints

Loratadine, like other antihistamines, can interfere with the results of diagnostic skin tests for allergens. To ensure accurate test results, the use of loratadine should be discontinued for at least 48 hours before any scheduled skin testing procedure. The concomitant ingestion of food may slightly delay the absorption of loratadine, but this effect is not known to impact its overall clinical action.

Advertisements

Mechanism of Action

Selective H1 Receptor Inverse Agonism

Lorastad acts by selective inverse agonism at peripheral Histamine H1 receptors, its sole primary molecular target. Both the parent drug (loratadine) and its active metabolite, desloratadine, bind to this receptor, stabilizing it in an inactive state. This mechanism actively prevents the signaling molecule, histamine, from activating the receptor and initiating the physiological cascade.

Modulation of Peripheral Vascular and Sensory Pathways

By blocking the H1 receptor, the drug interrupts the histamine-driven signaling in two key peripheral pathways. First, it prevents the cascade that causes the lining of the blood vessels (endothelium) to become leaky, resulting in attenuated exudation of plasma fluid into surrounding tissues. Second, it dampens the activation of sensory nerves, reducing the physiological signaling pathway for pruritus.

Sustained Action via Metabolic Selectivity

The mechanism's duration is linked to its minimal penetration of the blood-brain barrier (BBB). The body rapidly converts loratadine into the long-lived metabolite, desloratadine. This metabolic process ensures the H1 receptor blockade is maintained for a 24-hour period due to minimal central nervous system interaction.

Advertisements

Dosage and Administration Information

How to Use Lorastad (loratadine)

Loratadine is an antihistamine utilized according to standardized administration protocols. Its use is defined by a simple, non-divided dosing pattern.


Official Administration Guidelines

Instruction Detail
Route of Administration The oral route is the only approved method for all standard forms, including tablets, syrups, and orally disintegrating tablets (ODTs).
Timing & Meal Relation The medicine is taken once daily with a mandatory minimum interval of 24 hours between doses. Administration may be done with or without food.
Standard Dosing The typical dose for adults and children 6 years and older is 10 mg once daily. This is the maximum recommended dose in a 24-hour period.
Pediatric Dosing For children 2 to < 6 years, the prescribed dose is 5 mg once daily, typically administered via syrup or chewable tablet. The use and dose for children under 2 years must be determined by a healthcare provider.

Administration Specifics and Constraints

Certain constraints govern the proper intake of specific formulations. Orally disintegrating tablets (ODTs) are placed on the tongue to dissolve and can be swallowed with or without water, whereas chewable tablets must be crushed completely before swallowing.

Administration frequency must be adjusted in certain clinical contexts. For adult patients and children 6 years with severe hepatic impairment or renal insufficiency (creatinine clearance < 30 mL/min), the initial dose is reduced to 10 mg every other day. Furthermore, to avoid false-negative results, loratadine administration should be discontinued for at least 48 hours before any diagnostic skin testing.

Advertisements

Recent Clinical Evidence

Lorastad (loratadine): Recent Clinical Evidence

Loratadine is a second-generation antihistamine used for the relief of symptoms associated with allergic conditions, including seasonal allergic rhinitis (SAR), perennial allergic rhinitis, and chronic urticaria (hives). Clinical research on loratadine continues to reinforce its established profile as a selective peripheral H1 receptor antagonist.

Efficacy and Onset of Action

Studies consistently show that loratadine results in greater relief of allergy symptoms, such as sneezing, watery eyes, and nasal discharge, compared to placebo in adults and children (aged 6 and over). Recent analyses of clinical trials have focused on the drug's timeline of effect:

  • Onset of Symptom Relief: Symptom relief, measured by changes in total symptom scores (TSS) and total ocular symptom scores (TOSS), has been reported in clinical settings. The onset of action for relief of nasal and ocular symptoms in adults with SAR may begin within 75 minutes to 3 hours following administration.
  • Duration of Effect: The therapeutic effect of a single dose is generally sustained for up to 24 hours, supporting its once-daily use.

Safety and Comparative Trials

Clinical data indicates that loratadine is less likely to cross the blood-brain barrier than first-generation antihistamines, which helps minimize central nervous system (CNS) effects such as drowsiness or sedation. In comparative trials:

  • Tolerability: The incidence of sedation reported with loratadine is often similar to that reported with placebo.
  • Comparisons: Studies have compared loratadine's outcomes in treating allergic rhinitis against other second-generation antihistamines, such as fexofenadine and levocetirizine, and reported comparable efficacy profiles in symptom reduction for specific allergy types.

Ongoing clinical research continues to explore loratadine's role in combination therapies, such as fixed-dose combinations with corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs), for managing severe allergic rhinitis or common cold symptoms.

Key Studies & References

  1. Loratadine: A Review of its Antihistaminic Activity, Pharmacokinetics and Therapeutic Use in Allergic Disorders
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Lorastad (loratadine) (FAQ)


Q: Can Lorastad be taken with blood pressure medicine?

A: Official information primarily highlights interactions with specific enzyme inhibitors in the liver. Regulatory documents generally contain no specific warnings about using loratadine with common blood pressure medications. However, it is standard practice for patients taking multiple medications to review their regimen with a healthcare professional.


Q: Is it safe to take Lorastad every day for a long time?

A: Loratadine is designed to be a long-acting, once-daily medicine used to manage chronic allergic conditions, such as year-round hives. One regulatory body notes that use for an extended period, such as up to six months, is generally managed under the guidance of a healthcare professional.


Q: Can pregnant women or those who are breastfeeding use Lorastad?

A: Loratadine is not recommended for women who are breastfeeding because the substance is known to pass into breast milk. Official sources advise avoiding its use during pregnancy as a precautionary measure, although existing data has shown no clear signs of harm to the fetus or newborn.


Q: Does Lorastad affect birth control pills?

A: Regulatory documents listing drug-drug interactions for loratadine primarily focus on substances that affect the drug's metabolism in the liver. There are no documented interactions found between loratadine and standard oral contraceptive combinations in official US regulatory resources.


Q: What happens if Lorastad is taken with alcohol?

A: Studies examining loratadine's effect when taken at the same time as alcohol found no documented increase in the effects of alcohol on psychomotor performance. Despite this finding, official product information recommends exercising general caution, as with any medication, when consuming alcohol.


Q: Are there any official warnings about driving while taking Lorastad?

A: Clinical trials generally found no impairment in the ability to drive or use machinery, and the effect on attention is considered negligible. However, individuals are advised that, although rare, they should recognize potential effects on their ability to drive before operating machinery.


Q: How does Lorastad differ from desloratadine?

A: Loratadine is the drug taken by the patient, and desloratadine is the main active substance that is created in the body after loratadine is processed. This metabolite is largely responsible for the long-lasting anti-allergic effects, and it is also available as a separate medicine.


Q: What should I do if I think I've taken too much Lorastad?

A: Official labeling instructs patients not to exceed the recommended dose, as taking more may cause increased drowsiness. In case of a suspected overdose, official labeling instructs that medical help should be obtained or a Poison Control Center should be contacted right away.


Q: Can Lorastad be taken at night?

A: The medicine is a once-daily, 24-hour formulation. Official instructions state it can be taken once daily without specifying a time of day. This indicates that it can be taken at a time that aligns with the individual's daily routine, including an evening or nighttime administration.


Q: Is it common to feel a dry mouth while taking Lorastad?

A: Dry mouth is listed in official documents as a documented adverse event under 'Gastrointestinal disorders.' However, regulatory sources do not assign a frequency (such as common or uncommon) to this specific side effect.


Q: Can Lorastad be used for pet allergies?

A: Loratadine is officially indicated for the relief of symptoms associated with perennial (year-round) allergic rhinitis. This includes the symptomatic relief of perennial rhinitis caused by indoor allergens, which includes animal dander.


Q: Is Lorastad the same type of medicine as Benadryl?

A: Both are classified as antihistamines. However, loratadine (Lorastad) is a second-generation agent, while the active ingredient in Benadryl (diphenhydramine) is a first-generation agent. This difference is mainly linked to loratadine's non-sedating profile.


Q: Can children use Lorastad?

A: Yes, loratadine is officially approved for use in children who are two years of age and older. However, official regulatory guidance states that a healthcare provider must determine the appropriate form and amount for children under six years of age.


Q: If I miss a dose of Lorastad, what should I do?

A: If a dose is forgotten, it is officially instructed to be taken when it is remembered. However, patients are advised to not exceed taking more than one dose within a 24-hour period.


Q: What should I avoid eating or drinking when taking Lorastad?

A: Specific food items are generally not listed for avoidance in official patient information. Regulatory documents note that food may slightly slow down the absorption of the drug, but this effect is not known to impact its overall action.


Q: Is there a generic version of Lorastad (loratadine) available?

A: The active ingredient, loratadine, is available as a generic medicine and is recognized globally for its use in treating allergies. It is listed on the World Health Organization's List of Essential Medicines.


Q: Does Lorastad interact with pain relievers like ibuprofen?

A: Official drug interaction databases generally show no documented interactions between loratadine and standard nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. Official warnings are typically focused on medicines that affect the metabolism of loratadine.


Q: Is it safe for older adults (seniors) to take Lorastad?

A: Official guidance indicates that no specific dosage adjustment is required for the elderly. Loratadine is often preferred in this population due to its established low potential for causing drowsiness.


Q: Can Lorastad be used for coughs or colds?

A: Loratadine's primary use is for allergy symptoms like sneezing and runny nose. It is also approved for sale in combination products with pseudoephedrine, which is used to help relieve symptoms associated with the common cold.


Q: Does Lorastad interact with supplements like St. John's Wort?

A: St. John's Wort is an herbal supplement known to potentially affect liver enzymes that process loratadine. Official information suggests St. John's Wort could reduce the amount of loratadine in the body, potentially lowering its effectiveness.


Q: Why is loratadine sometimes combined with pseudoephedrine?

A: Loratadine is combined with pseudoephedrine because the latter is a decongestant. The combination is approved to provide relief for allergy symptoms, particularly a stuffy nose, by helping to reduce swelling of the nasal passages.


Q: Are there different strengths of Lorastad available?

A: Yes, official product labeling indicates that different strengths are available to match different populations. This includes a standard 10 mg dose for adults and older children, and a 5 mg dose available in liquid or chewable forms for younger children.


Q: Does Lorastad affect sleep patterns?

A: Loratadine is widely supported by clinical evidence for its non-sedating profile. Regulatory documents, however, list rare instances of both drowsiness (somnolence) and insomnia as potential side effects.


Q: What is the difference between Lorastad tablets and the liquid form?

A: Both the tablet and the liquid (syrup/solution) forms contain the same active ingredient and are designed to provide 24-hour relief. The liquid form is typically prescribed for younger children to ensure accurate dosing and easier administration.


Q: Are there specific food interactions noted for Lorastad?

A: No specific food items are officially restricted. While taking the drug with food may slightly delay absorption, regulatory documents state that this effect does not significantly alter the overall efficacy of the medicine.


Q: What is the half-life of loratadine in the body?

A: Official pharmacokinetic data shows that the loratadine parent drug has a half-life of about 8 hours. However, its active metabolite, desloratadine, has a much longer half-life of about 27 hours, which is why the medicine works for a full 24 hours.


Q: Does Lorastad have an effect on heart rate?

A: Regulatory sources list adverse effects involving the heart, such as tachycardia (fast heart rate) and palpitation, as documented 'Very Rare' adverse reactions. Overall, it is considered to have a low risk of cardiovascular side effects.


Q: Can Lorastad affect liver function tests?

A: Official documentation notes that 'Abnormal hepatic function' is a 'Very Rare' adverse reaction. Regulatory guidance notes that individuals with existing severe liver conditions may require a dose adjustment due to reduced drug processing.


Q: Is there evidence for Lorastad causing weight changes?

A: Official documentation lists 'weight increased' as a documented finding under the 'Investigations' body system. However, the frequency of this specific finding is listed as 'Not Known' in regulatory sources.


Q: Does Lorastad lose effectiveness if it gets exposed to heat?

A: Official instructions require the medicine to be stored at a Controlled Room Temperature (20 C to 25 C or 68 F to 77 F) and to be protected from excessive moisture. Exposure to excessive heat can lead to the drug's degradation, which carries the risk of reduced effectiveness.


Q: Are there any documented interactions between Lorastad and asthma medications?

A: Official interaction warnings are focused on specific enzyme inhibitors and sedating medicines. There are generally no specific documented interactions in official sources between loratadine and standard asthma maintenance or rescue inhalers.


Q: Can teenagers use Lorastad?

A: Yes, official dosing information confirms that the standard adult dose of 10 mg once daily is the prescribed dosage for adolescents and children aged six years and older.


Advertisements

How should Lorastad (loratadine) be stored and disposed of?

How to Store and Dispose of Lorastad (loratadine)?

Storage Requirements

Loratadine tablets must be stored at Controlled Room Temperature, which is defined by regulatory agencies as a temperature range between 20°C and 25°C (68°F and 77°F). The medication must be protected from excessive moisture and, in some forms, protected from light and freezing. To maintain product stability, it is required to store the medicine in the original packaging.

Child Safety and Container Integrity

The product must be kept out of reach of children. The packaging should be inspected; the medicine should not be used if the blister unit is torn or the bottle's seal is broken or missing.

Disposal Instructions

Disposal of unused or expired loratadine must be carried out in accordance with local regulations. It is an environmental restriction to avoid release to the environment; the product should not be disposed of into water courses, sewage systems, or ground water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lorastad (loratadine) found in:

A-Z Index: